Site Search
Site Search
Displaying results 751 - 760 of 893
National Info Days on IMI 2
Members of IMI’s States Representatives Group and others are organising national info sessions on IMI 2 throughout the second half of 2014. The events are taking place in several EU member states and include an overview of IMI 2’s funding and intellectual property (IP) rules ...
Innovative Medicines Initiative to recruit new Executive Director
For immediate release IMI/OUT/2014-02072 Mandate of current Executive Director is non-renewable and ends in December 2014 New Executive Director will be expected to manage IMI to highest standards and ensure its continued success Deadline for applications is 16 July 2014 BRUSSELS ...
IMI 2 - 1st Call webinars
IMI held webinars on topics of its 1st Call for proposals under IMI 2 , as well as its new rules and procedures and intellectual property rights (IPR) in July 2014. All webinars on the Call topics featured a presentation by the EFPIA topic coordinator, as well as time for ...
IMI 2 Open Info Day 2014
IMI held its IMI 2 Open Info Day in Brussels on Tuesday 30 September 2014 . The event was well-attended, with more than 290 people participating either in person or remotely via the webcast. On top of a review of the new IMI 2 rules and Call procedures, IMI's founding partners ...
35th Edition – May 2014
Table of contents:
- IMI 2 – Call 1 indicative topic texts online
- Webinar organised by Fit for Health 2.0 on IMI 2
- IMI Stakeholder Forum 2014 – presentations now available!
- IMI - JDRF Diabetes Patient Focus meeting
- IMI 2 legislation approved by Council
- New report highlights quality and quantity of IMI project research outputs
- News from the projects
34th Edition – April 2014
Table of contents:
SME in the spotlight: Taros Chemicals – the right chemistry
German SME Taros Chemicals boasts expertise in synthetic and medicinal chemistry and hit-to-lead development. The company is a key player in IMI’s European Lead Factory project, which is developing a major new pan-European platform for drug discovery comprising a large compound ...
UCB CEO, Roch Doliveux, to chair Innovative Medicines Initiative board for a second term
For immediate release IMI/OUT/2014-01199 Roch Doliveux to spearhead industry’s commitment to world’s biggest public-private partnership in biopharmaceutical research and innovation BRUSSELS, 1 April 2014 – UCB and IMI announced today that UCB CEO Roch Doliveux has again been ...
IMI - JDRF Diabetes Patient Focus meeting
New: Videos from the event are now available here . More than 100 people attended and around 50 watched the live webstream of the IMI - JDRF Diabetes Patient Focus meeting, which took place on Tuesday 20 May at the Hotel Crowne Plaza - Le Palace in Brussels, Belgium ...
